Ivaq 5mg Tablet
Marketer
Qualchem Healthcare Pvt Ltd
Salt Composition
Ivabradine (5mg)
Overview Ivaq 5mg Tablet
Angina and chronic heart failure are treated with the medication, Ivaq 5mg Tablet. This medication improves cardiac efficiency by reducing heart rate, thus alleviating chest pain and lowering the risk of hospitalization in heart failure patients. Dosage varies depending on the condition being treated. As treatment for these conditions is typically lifelong, discontinuation requires prior consultation with a physician. Consistent daily intake with food is recommended. Overdose can cause excessive heart rate slowing, leading to fatigue and shortness of breath; seek immediate medical attention if this occurs. Common side effects include transient visual disturbances, bradycardia, hypertension, atrial fibrillation, dizziness, blurred vision, and electrocardiographic changes. Serious adverse effects, like syncope and significant heart rhythm alterations, warrant prompt medical care. Refrain from driving until the medication's effects are known. Ivaq 5mg Tablet is contraindicated in patients with severe hepatic impairment, bradycardia, cardiac arrhythmias, hypotension, or recently exacerbated heart failure. Interactions exist with certain antihypertensives, antifungals, and antiretrovirals. Its use is prohibited during pregnancy, attempts at conception, and lactation.
Primary Ingredients of Ivaq 5mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Ivaq 5mg Tablet
Managing angina pectoris and heart failure.
Major Benefits of Ivaq 5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 5mg Ivaq tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with food.
Common Side effects of Ivaq 5mg Tablet:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Ivaq 5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Ivaq 5mg Tablet should be administered with a meal.
How Ivaq 5mg Tablet works:
Cardioquin 5mg tablets decrease cardiac rate. This medication achieves its effect by slowing the heartbeat, thereby diminishing the heart's oxygen demand and improving its overall function.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while taking Ivaq 5mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyUNSAFE
Using Ivaq 5mg tablets during pregnancy carries a high risk. Pregnant women should consult their physician before use, as research in both animals and humans indicates potentially serious harm to the unborn child.
Breast feedingUNSAFE
Breastfeeding mothers should not take Ivaq 5mg Tablets. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Ivaq 5mg Tablet, a medication that can induce transient visual disturbances, primarily phosphenes. Night driving, in particular, should be approached cautiously given the potential for these light flashes.
KidneyCAUTION
Caution is advised when administering Ivaq 5mg Tablets to individuals with severely impaired kidney function. Dosage modification for Ivaq 5mg Tablets might be necessary. Physician consultation is recommended. Data regarding Ivaq 5mg Tablet use in patients with severe renal impairment is limited.
LiverCAUTION
For individuals with liver impairment, Ivaq 5mg Tablets require careful administration, potentially necessitating dosage modification. Physician consultation is advised. The use of Ivaq 5mg Tablets is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Ivaq 5mg Tablet :
Omit any missed Ivaq 5mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Ivaq 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzazepine compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Behavioral Class | Sodium channel blockers targeting the sinoatrial node (I<sub>f</sub> current) |
3,018 People bought this recently